Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
This approval provides a new option for long-term disease control in patients, w...
Akums Drugs & Pharmaceuticals has received its first product approval from the ...
Arjit Agarwal, Principal Consultant, Business Consulting, Nexdigm highlights th...
Kishan Kumar, MBA Graduate Student, Southern Connecticut State University, US p...
An engaging Plenary discussion on India’s Path to Biopharmaceutical Leadership:...
The agreement focuses on expanding Lymphir’s international access via country-sp...
The therapies are approved as second or third line treatment for adults with pla...
Jatin Takkar, Head – Product Safety & Regulatory, Siegwerk India argues for a s...
Introduction In 2026, large-scale nutritional surveys continue to reveal a conce...
Rx Propellant, science and R&D infrastructure platform established by Actis, gr...
Excipients are becoming a strategic lever in India’s move toward high-value, gl...
AI is reshaping pharma commercialisation, transforming how companies engage hea...
Under the agreement, Biocodex will hold an exclusive worldwide licence to develo...
The companies plan to jointly develop at least two research and development (R&D...
Nandakumar Kalathil, Country General Manager – India, Agilent Technologies, sha...
Exclusive partnership with Hikma Pharmaceuticals to commercialise product acros...
